Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on (R) 4 chloro 3 hydroxybutyric acid ethyl ester. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel ketoreductase mutant enables high-purity pharmaceutical intermediates manufacturing with substantial cost reduction and enhanced supply chain reliability for global partners.
Patent CN114908129B reveals a novel dehydrogenase mutant for high-purity (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering significant cost and supply chain advantages.
Patent CN105543186A reveals novel biocatalytic route for high-purity chiral alcohols. Enables cost reduction in chiral alcohol manufacturing and supply chain reliability.
Patent CN113652408A reveals a novel carbonyl reductase mutant for efficient (R)-4-chloro-3-hydroxybutyric acid ethyl ester production, offering superior yield and green manufacturing advantages.